Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

KERR CORPORATION — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report

KERR CORPORATION

via SQUIRE PATTON BOGGS

2nd Quarter (Apr 1 - June 30) · 2008Posted Jul 21, 2008Filing document ↗LDA record ↗

Income$20Kfee reported

Client

Name: KERR CORPORATION
Description: Manufactures dental equipment.
Location: California · United States of America

Registrant

Firm: SQUIRE PATTON BOGGS
Description: Law Firm
Location: WASHINGTON, District of Columbia, United States of America

Lobbying activities

1 issue

Pharmacy
FDA enforcement action against counterfeits of client's medical devices.
Lobbyistsms SMITHA GOTTIMUKKALA STANSBURY · mr PAUL D RUBIN
TargetedHOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.